Prostate cancer patients and their doctors may want to think twice about the best timing for chemotherapy or radiation therapy in conjunction with a common nonsurgical treatment, based on international research findings led by UT Southwestern Medical Center investigators.
High dose of radiation may not be beneficial on low-risk prostate cancer, according to the experts.
AtВ Thomas Jefferson UniversityвЂ™s Cancer Center in Philadelphia, there was a research about theВ radiation andВ prostate cancer. TheВ study can be found in American Journal of Clinical Oncology recently.
It was often thought thatВ if the highest dose of radiation a body can tolerate will be the best way to kill the prostate cancer but the result somewhat turns to different, saidВ Dr. Robert Den.
The results of the research shows thatВ it is not alwaysВ goodВ to treat low-risk prostate cancer patientВ this way.
Researcher have viewed 12 studiesВ on this topic inВ which was included 6,800 patients. The result of this treatments isВ toВ result to drop in prostate specific antigen (PSA).
The higher doses of radiation doesn’t alwaysВ lowerВ the rates of prostate cancer.
It is important to check our assumptions, because the overall study tells us that the PSA test is not much benefit for the patients as the researcher expected, saidВ Adam Dicker.
This study needsВ furtherВ clinical trials and also an interpretation of current and previous studies.